The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
C-reactive protein, inflammation and coronary heart disease
Open accessAbstract
Inflammation is widely considered to be an important contributing factor of the pathophysiology of coronary heart disease (CHD), and the inflammatory cascade is particularly important in the atherosclerotic process. In consideration of the important role that inflammatory processes play in CHD, recent work has been focused on whether biomarkers of inflammation may help to improve risk stratification and identify patient groups who might benefit from particular treatment strategies. Of these biomarkers, C-reactive protein (CRP) has emerged as one of the most important novel inflammatory markers. CRP an acute phase protein is synthesized by hepatocytes in response to proinflammatory cytokines, in particular interleukin-6. Many large-scale prospective studies demonstrate that CRP strongly and independently predicts adverse cardiovascular events, including myocardial infarction, ischemic stroke, and sudden cardiac death in individuals both with and without overt CHD. CRP is believed to be both a marker and a mediator of atherosclerosis and CHD. CRP plays a pivotal role in many aspects of atherogenesis including, activation of complement pathway, lipids uptake by macrophage, release of proinflammatory cytokines, induces the expression of tissue factor in monocytes, promotes the endothelial dysfunction and inhibits nitric oxide production. The commercial availability of CRP high sensitive assays has made screening for this marker simple, reliable, and reproducible and can be used as a clinical guide to diagnosis, management, and prognosis of CHD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07492-2 · Cited by 7,007
Pearson, T. A., Mensah, G. A., Alexander, R. W., Anderson, J. L., Cannon, R. O., Criqui, M., Fadl, Y. Y., Fortmann, S. P., Hong, Y., Myers, G. L., et al. (2003) · Circulation · doi:10.1161/01.cir.0000052939.59093.45 · Cited by 6,401
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
Ridker, P. M., Cushman, M., Stampfer, M. J., Tracy, R. P., & Hennekens, C. H. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361401 · Cited by 5,504
C-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci18921 · Cited by 3,503
Global atlas on cardiovascular disease prevention and control.
Mendis, S., Puska, P., & Norrving, B. G. (2011) · Virtual Defense Library (Ministerio de Defensa) · Cited by 3,441
C-reactive protein: a critical update
Pepys, M. B., & Hirschfield, G. M. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200318921 · Cited by 3,436
C-Reactive Protein Levels and Outcomes after Statin Therapy
Ridker, P. M., Cannon, C. P., Morrow, D., Rifai, N., Rose, L. M., McCabe, C. H., Pfeffer, M. A., & Braunwald, E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042378 · Cited by 2,292
Koenig, W., Sund, M., Fröhlich, M., Fischer, H.-G., Löwel, H., Döring, A., Hutchinson, W. L., & Pepys, M. B. (1999) · Circulation · doi:10.1161/01.cir.99.2.237 · Cited by 1,964
Writing Committee Members, Greenland, P., Alpert, J. S., Beller, G. A., Benjamin, E. J., Budoff, M. J., Fayad, Z. A., Foster, E., Hlatky, M. A., Hodgson, J. M., et al. (2010) · Circulation · doi:10.1161/cir.0b013e3182051b4c · Cited by 1,873
Ridker, P. M., Buring, J. E., Shih, J., Matias, M., & Hennekens, C. H. (1998) · Circulation · doi:10.1161/01.cir.98.8.731 · Cited by 1,642
Serological reactions in pneumonia with a non-protein somatic fraction of Pneumococcus
Tillett, W. S., & Francis, T. (1930) · Journal of Experimental Medicine · doi:10.1084/jem.52.4.561 · Cited by 1,482
Immune and Inflammatory Mechanisms of Atherosclerosis
Galkina, E., & Ley, K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132620 · Cited by 1,437
Inflammation as a Cardiovascular Risk Factor
Willerson, J. T., & Ridker, P. M. (2004) · Circulation · doi:10.1161/01.cir.0000129535.04194.38 · Cited by 1,304
Inflammation in Atherosclerosis: From Vascular Biology to Biomarker Discovery and Risk Prediction
Packard, R. R. S., & Libby, P. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.097360 · Cited by 925
Tracy, R. P., Lemaitre, R. N., Psaty, B. M., Ives, D. G., Evans, R. W., Cushman, M., Meilahn, E. N., & Kuller, L. H. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.6.1121 · Cited by 836
Inflammation in Atherosclerosis: Transition From Theory to Practice
Libby, P., Okamoto, Y., Rocha, V. Z., & Folco, E. (2010) · Circulation Journal · doi:10.1253/circj.cj-09-0706 · Cited by 799
Monocyte-Endothelial Cell Interactions in the Development of Atherosclerosis
Mestas, J., & Ley, K. (2008) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2008.11.004 · Cited by 548
Translating molecular discoveries into new therapies for atherosclerosis
Rader, D. J., & Daugherty, A. (2008) · Nature · doi:10.1038/nature06796 · Cited by 515
Nitric oxide and atherosclerosis: An update
Napoli, C., de Nigris, F., Williams-Ignarro, S., Pignalosa, O., Sica, V., & Ignarro, L. J. (2006) · Nitric Oxide · doi:10.1016/j.niox.2006.03.011 · Cited by 463
Epidemiology and causation of coronary heart disease and stroke in India
Gupta, R., Joshi, P., Mohan, V, Reddy, K. S., & Yusuf, S. (2008) · Heart · doi:10.1136/hrt.2007.132951 · Cited by 463
C‐reactive protein and coronary heart disease: a critical review
Casas, J. P., Shah, T., Hingorani, A. D., Danesh, J., & Pepys, M. B. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.02015.x · Cited by 366
Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction.
de Beer, F. C., Hind, C. R., Fox, K. M., Allan, R. M., Maseri, A., & Pepys, M. B. (1982) · Heart · doi:10.1136/hrt.47.3.239 · Cited by 358
C-reactive protein and the biology of disease
Ansar, W., & Ghosh, S. (2013) · Immunologic Research · doi:10.1007/s12026-013-8384-0 · Cited by 336
THE OCCURRENCE DURING ACUTE INFECTIONS OF A PROTEIN NOT NORMALLY PRESENT IN THE BLOOD
Abernethy, T. J., & Avery, O. T. (1941) · Journal of Experimental Medicine · doi:10.1084/jem.73.2.173 · Cited by 286
THE OCCURRENCE DURING ACUTE INFECTIONS OF A PROTEIN NOT NORMALLY PRESENT IN THE BLOOD
MacLeod, C. M., & Avery, O. T. (1941) · Journal of Experimental Medicine · doi:10.1084/jem.73.2.183 · Cited by 261
C-reactive protein in atherosclerosis: A causal factor?
PAFFEN, E., & DEMAAT, M. (2006) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.03.004 · Cited by 226
C-reactive protein: a new risk assessment tool for cardiovascular disease.
Clearfield, M. B. (2005) · PubMed · Cited by 197
Inflammatory markers in coronary heart disease
Madjid, M., & Willerson, J. T. (2011) · British Medical Bulletin · doi:10.1093/bmb/ldr043 · Cited by 114
Pfützner, A., Schöndorf, T., Hanefeld, M., & Forst, T. M. (2010) · Journal of Diabetes Science and Technology · doi:10.1177/193229681000400326 · Cited by 107
THE OCCURRENCE DURING ACUTE INFECTIONS OF A PROTEIN NOT NORMALLY PRESENT IN THE BLOOD
McCarty, M. (1947) · The Journal of Experimental Medicine · doi:10.1084/jem.85.5.491 · Cited by 98
Coronary Heart Disease Risk Factors
Torpy, J. M. (2009) · JAMA · doi:10.1001/jama.302.21.2388 · Cited by 94
Calabrò, P., Golia, E., & Yeh, E. T. H. (2011) · Current Pharmaceutical Biotechnology · doi:10.2174/138920112798868764 · Cited by 71
Camhi, S. M., Stefanick, M. L., Ridker, P. M., & Young, D. R. (2009) · Metabolism · doi:10.1016/j.metabol.2009.07.008 · Cited by 67
Arroyo‐Espliguero, R., y, P. A., Quiles, J., & Kaski, J. C. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.08.009 · Cited by 64
Imes, C. C., & Austin, M. A. (2012) · Biological Research For Nursing · doi:10.1177/1099800412436967 · Cited by 63
Level of C-Reactive Protein as a Measure of Acute Myocardial Infarction.
Kroop, I. G., & Shackman, N. H. (1954) · Experimental Biology and Medicine · doi:10.3181/00379727-86-21019 · Cited by 54
C-reactive protein, cytokines and inflammation in cardiovascular diseases
Bucová, M., Bernadic, M., & Buckingham, T. H. (2008) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.1007/bf03657063 · Cited by 45
Świątkiewicz, I., Koziński, M., Magielski, P., Fabiszak, T., Sukiennik, A., Navarese, E. P., Odrowąż‐Sypniewska, G., & Kubica, J. (2012) · Mediators of Inflammation · doi:10.1155/2012/250867 · Cited by 38
Raposeiras‐Roubín, S., Pardal, C. B., Roubín-Camiña, F., Sánchez, R. O., Álvarez, E., Paradela‐Dobarro, B., García‐Acuña, J. M., Aguiar‐Souto, P., Jacquet-Hervet, M., Castromán, M. J., et al. (2013) · Revista Portuguesa de Cardiologia (English Edition) · doi:10.1016/j.repc.2012.05.026 · Cited by 30
C-reactive protein and coronary heart disease - risk marker or risk factor?
Davis, F. J., Vidyasagar, S., & Maiya, G. A. (2012) · The Journal of Clinical and Scientific Research · doi:10.15380/2277-5706.jcsr.12.040 · Cited by 15
Cited by
Using machine learning approaches for multi-omics data analysis: A review
Reel, P. S., Reel, S., Pearson, E., Trucco, E., & Jefferson, E. (2021) · Biotechnology Advances · doi:10.1016/j.biotechadv.2021.107739 · Cited by 903
Management of psoriasis as a systemic disease: what is the evidence?
Korman, N. J. (2020) · British Journal of Dermatology · doi:10.1111/bjd.18245 · Cited by 539
Latic, N., & Erben, R. G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186483 · Cited by 283
Avan, A., Tavakoly Sany, S. B., Ghayour‐Mobarhan, M., Rahimi, H. R., Tajfard, M., & Ferns, G. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26791 · Cited by 182
Cardiovascular Protective Effects of Centella asiatica and Its Triterpenes: A Review
Razali, N. N. M., Ng, C. T., & Fong, L. Y. (2019) · Planta Medica · doi:10.1055/a-1008-6138 · Cited by 95
Metadata
- Authors
- Shrivastava, A. K., Singh, H. V., Raizada, A., & Singh, S. K.
- Venue
- The Egyptian Heart Journal
- Published
- 2015-06
- Volume
- 67
- Issue
- 2
- Pages
- 89-97
- ISSN
- 1110-2608 (ISSN-L)
- OpenAlex
- W2042401120
- Cited by
- 320
- References
- 41
- FWCI
- 11.95
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.